Success Metrics

Clinical Success Rate
86.5%

Based on 32 completed trials

Completion Rate
86%(32/37)
Active Trials
8(15%)
Results Posted
16%(5 trials)
Terminated
5(9%)

Phase Distribution

Ph not_applicable
13
24%
Ph phase_3
6
11%
Ph phase_2
5
9%
Ph early_phase_1
2
4%
Ph phase_1
2
4%

Phase Distribution

4

Early Stage

5

Mid Stage

6

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
2(7.1%)
Phase 1Safety & dosage
2(7.1%)
Phase 2Efficacy & side effects
5(17.9%)
Phase 3Large-scale testing
6(21.4%)
N/ANon-phased studies
13(46.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

82.1%

32 of 39 finished

Non-Completion Rate

17.9%

7 ended early

Currently Active

8

trials recruiting

Total Trials

54

all time

Status Distribution
Active(8)
Completed(32)
Terminated(7)
Other(7)

Detailed Status

Completed32
unknown7
Recruiting6
Terminated5
Withdrawn2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
54
Active
8
Success Rate
86.5%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (7.1%)
Phase 12 (7.1%)
Phase 25 (17.9%)
Phase 36 (21.4%)
N/A13 (46.4%)

Trials by Status

recruiting611%
terminated59%
withdrawn24%
unknown713%
active_not_recruiting24%
completed3259%

Recent Activity

8 active trials
Showing 5 of 54
active_not_recruitingphase_2

Treatment of Hemochromatosis

NCT00007150
recruitingnot_applicable

Restrictive Fluid Management In Liver Transplantation (REFIL)

NCT05647733
recruitingnot_applicable

Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia

NCT07288827
active_not_recruitingearly_phase_1

Evaluating the Human Immune Response to the JYNNEOS Vaccine

NCT06366672
completedphase_2

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

NCT04182100
View all 54 trials

Clinical Trials (54)

Showing 20 of 54 trialsScroll for more
NCT00007150Phase 2

Treatment of Hemochromatosis

Active Not Recruiting
NCT05647733Not Applicable

Restrictive Fluid Management In Liver Transplantation (REFIL)

Recruiting
NCT07288827Not Applicable

Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia

Recruiting
NCT06366672Early Phase 1

Evaluating the Human Immune Response to the JYNNEOS Vaccine

Active Not Recruiting
NCT04182100Phase 2

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

Completed
NCT07121998

Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms

Recruiting
NCT05676099

TSC Biosample Repository and Natural History Database

Recruiting
NCT00568490

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Recruiting
NCT05396170

Effect of Phlebotomy on Heartrate in Polycythemia Patients

Recruiting
NCT06002490Phase 3

A Study to Evaluate P1101 in Japanese PV Patients

Completed
NCT03203850Phase 2

Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)

Terminated
NCT02375165

Biomarkers for the Detection of Lymphatic Insufficiency

Unknown
NCT05064267

Hemostatic Profiles in Pediatric CKD

Completed
NCT02304874Not Applicable

Evaluation of Body Iron Stores in Overweight Healthy Volunteers

Completed
NCT01045525Phase 3

Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic Liversiderosis

Completed
NCT01573754Phase 2

Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda

Completed
NCT02460445Not Applicable

Phlebotomy and Polycystic Ovary Syndrome

Completed
NCT00568282

Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients

Completed
NCT04308889Early Phase 1

Pro-Resolving Mediators in Acute Inflammation in Humans

Completed
NCT03741517

Biomarker Study of Pancreatic Neuroendocrine Tumours

Unknown

Drug Details

Intervention Type
PROCEDURE
Total Trials
54